Eris Lifesciences to Acquire Remaining 30% in Swiss Parenterals

Eris Lifesciences, a company that makes medicines, is buying the last 30% of another company called Swiss Parenterals.

They will pay ₹423 crore for this, and instead of money, they will give shares of their own company to the seller, Naishadh Shah.

Eris already owns 70% of Swiss Parenterals, which they bought last year.

They want to make more medicines together, especially ones that are safe to inject.

Naishadh Shah will become the boss of Swiss Parenterals.

Eris is also buying other medicine brands from different companies to become stronger.

They think next year will be a big year for their business outside India.